Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells
- PMID: 2229068
Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells
Abstract
The expression of human immunodeficiency virus 1 (HIV-1) envelope glycoprotein products was studied in cells transfected with env gene constructs transcribed from an SV40 promoter. Gene constructs possessing the complete tat, rev (tat+ rev+) and env genes were transiently expressed in COS-1 cells as precursor SU-TM (gp160), SU.TM (gp120 x 41), and nucleolar rev protein. In addition, envelope glycoprotein was detected on the surface of those transfected COS-1 cells expressing abundant levels of env protein. Transfected constructs possessing a mutated tat translational initiation codon (tat-rev+) were expressed in COS-1 cells with at least a 10-fold increase in the level of envelope glycoprotein expression compared to the analogous constructs with an intact tat AUG codon (tat+ rev+). Mutation of the rev initiation codon (tat+ rev-) and (tat-rev-) resulted in no detectable expression of env products but expression of these proteins could be rescued by co-transfection of a cDNA encoding the rev gene. Subgenomic tat/rev transcripts were detected following transfection of all of the gene constructs indicating splicing of the env mRNAs transcribed from a heterologous promoter. Unspliced env transcripts were only detected in the cytoplasm of cells transfected with (rev+) constructs or with the (tat- rev-) construct in the presence of the rev cDNA supplied in trans. In contrast, unspliced transcripts were detected in the nuclear and total cellular RNA of all transfected cells. Expression of rev protein was localized to the nucleolus of transfected COS-1 cells. These results indicate that the export of unspliced env mRNA to the cytoplasm is facilitated by the expression of rev. Following env synthesis, the conversion of SU-TM (gp160) to SU.TM (gp120 x 41) was not quantitative. After a 20-h pulse-chase, only 40% of the SU-TM (gp160) present at the start of the chase period was subsequently accountable as mature SU (gp120), and approximately 30% of the detectable SU (gp120) was found in the culture medium of transfected COS-1 cells. The findings indicate that the surface expression of SU.TM (gp120 x 41) derived from heterologous gene transcripts is modulated (i) the co-expression of rev, (ii) the efficiency of proteolytic processing of SU-TM (gp160), and (iii) the degree of SU (gp120) shedding and/or secretion from the cell.
Similar articles
-
Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.J Virol. 1989 Nov;63(11):4875-81. doi: 10.1128/JVI.63.11.4875-4881.1989. J Virol. 1989. PMID: 2677405 Free PMC article.
-
Regulation of HIV-1 envelope protein synthesis by Tat and Rev in 293 cells.Virology. 1993 Sep;196(1):122-9. doi: 10.1006/viro.1993.1460. Virology. 1993. PMID: 8356789
-
High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.Virology. 1990 Apr;175(2):535-47. doi: 10.1016/0042-6822(90)90438-w. Virology. 1990. PMID: 2183470
-
HIV-1 replication.Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. doi: 10.1023/a:1021070512287. Somat Cell Mol Genet. 2001. PMID: 12465460 Review.
-
Rev-dependent expression of three species of HIV-1 mRNAs (review).Int J Mol Med. 1999 Mar;3(3):297-302. doi: 10.3892/ijmm.3.3.297. Int J Mol Med. 1999. PMID: 10028055 Review.
Cited by
-
Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expression.J Virol. 2001 Jun;75(11):5263-76. doi: 10.1128/JVI.75.11.5263-5276.2001. J Virol. 2001. PMID: 11333908 Free PMC article.
-
Rate and severity of HIV-associated dementia (HAD): correlations with Gp41 and iNOS.Mol Med. 1999 Feb;5(2):98-109. Mol Med. 1999. PMID: 10203575 Free PMC article.
-
Randomized Clinical Trial to Assess the Impact of the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 on HIV-1 Persistence in Individuals on Effective ART.Open Forum Infect Dis. 2018 Oct 20;5(10):ofy242. doi: 10.1093/ofid/ofy242. eCollection 2018 Oct. Open Forum Infect Dis. 2018. PMID: 30364428 Free PMC article.
-
Role of the HIV gp120 conserved domain 1 in processing and viral entry.J Biol Chem. 2008 Nov 21;283(47):32644-9. doi: 10.1074/jbc.M806099200. Epub 2008 Sep 24. J Biol Chem. 2008. PMID: 18815131 Free PMC article.
-
The C-terminal tail of the gp41 transmembrane envelope glycoprotein of HIV-1 clades A, B, C, and D may exist in two conformations: an analysis of sequence, structure, and function.Virology. 2005 Jul 5;337(2):284-96. doi: 10.1016/j.virol.2005.04.015. Virology. 2005. PMID: 15913700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources